Chronic obstructive pulmonary disease (COPD) may not be the most familiar sounding name for a health condition. And yet, it’s the third most common cause of death by disease in the United States. More than 15.3 million Americans suffer from COPD, a disease that often leads to a lowered quality of…
/PRNewswire/ — Just a few years ago, not many people knew what CBD is… or does. Things have really changed so much so that now, it’s harder to find someone…Read More……
A study evaluated the single-dose oral pharmacokinetics of cannabidiol and the safety profile of 12-week administration in healthy dogs and cats. Eight of each species were given a 2 mg/kg total CBD concentration orally twice daily for 12 weeks. The study suggests that cats may absorb orRead More……
The easing of the regulations governing GW Pharmaceuticals’ groundbreaking epilepsy drug in the UK will be followed by wider availability in Europe as pricing and reimbursement discussions continue.Read More……
GW Pharmaceuticals’ Epidyolex has been rescheduled in the UK, making life easier for patients, healthcare professionals and pharmacists.Read More……
Jun 24, 2020 – Anxiety is the number one ailment that CBD consumers report.Read More……
This report on Cannabidiol (CBD) market has keen to several extents of analysis – industry research (global industry trends) and Cannabidiol (CBD) market share analysiRead More……
GW’s cannabis-based medicine rescheduled following approval by the European Medicines Agency (EMA) and an independent assessment by the Advisory Council on…Read More……
Four major U.S consumer groups are urging Congress to reject proposals to fast-track approval of CBD use in dietary supplements and food products.Read More……
Read More……
